Business & startups Femtech World Awards Events

Women’s Health Week Europe launches two specialised pitch competitions to accelerate innovation

By Published On: July 7, 2025
Women’s Health Week Europe launches two specialised pitch competitions to accelerate innovation

Following the success of standout alumni like Impli and Hera Biotech, Women’s Health Week Europe doubles down on innovation with two targeted startup showcases.

Women’s Health Week Europe, the continent’s largest dedicated women’s health event, has announced the opening of applications for its expanded innovation showcase — now featuring two specialized pitch competitions designed to fast-track breakthrough solutions across the women’s health ecosystem.

Building on a track record of launching growth-stage companies like Impli and Hera Biotech, this year’s competition introduces two targeted tracks to reflect the growing breadth of innovation:

Therapeutic & Med Device Showcase

For clinically focused solutions in oncology, cardiovascular and autoimmune health, reproductive care, contraception, maternal and pelvic health, menopause (via HRT, diagnostics, or devices), clinical mental health (including DTx and medical devices), and bone health.

Consumer & Tech Showcase

For direct-to-consumer solutions in menstrual and sexual health, sleep, dermatology, holistic wellness, mental health (via wellness apps, community platforms, or self-care tools), and menopause management through tracking and wellness products.

The competitions will take place at the Barbican Centre in London on 16–17 October 2025 as part of Women’s Health Week Europe, giving selected startups direct access to top-tier investors, global corporates, and strategic partners actively seeking opportunities in the rapidly growing women’s health market.

“The women’s health sector is experiencing unprecedented momentum,” said Molly

Taylor, Head of Content at Women’s Health Week Europe.

“By expanding into two specialised showcases, we’re ensuring that innovations — from clinical therapeutics to consumer wellness — gain direct access to the capital and connections they need to scale.”

A Market Ripe for Disruption

The global women’s health market is projected to reach $60 billion by 2027, fueled by rising awareness, rapid technological advancement, and increased investment in historically underserved areas.

These pitch competitions aim to accelerate this progress by connecting cutting-edge startups with the capital and partnerships needed to bring their solutions to market.

What Applicants Receive

All applicants — regardless of selection status — will benefit from high-value exposure and access:

  • Access to Founders Day programming
  • Featured listing in the official startup directory
  • Networking with investors, multinationals, and sector experts
  • Full event access to Women’s Health Week Europe
  • One-to-one investor meetings through curated matchmaking

Finalists additionally receive:

  • Live pitch opportunity before leading European investors and industry leaders
  • High-impact visibility and validation among potential partners and funders

Proven Results

The competition has a strong track record of success.

Previous winners and participants have secured significant funding, forged strategic partnerships, and unlocked new market opportunities — validating the platform’s power to connect innovation with investment and scale.

Application Details

Deadline: 19 September 2025

Location: Barbican Centre, London

To Apply: Submit a pitch deck and secure an event ticket (early-bird pricing

currently available)

Apply now: https://bit.ly/400EoZc

About Women’s Health Week Europe

Women’s Health Week Europe is the continent’s premier gathering of innovators, investors, healthcare providers, and industry leaders focused on advancing women’s health.

From startup showcases and strategic matchmaking to interactive workshops and investor roundtables, the event is designed to catalyze commercial growth and health impact across the women’s health ecosystem.

Mumbai’s Luma Fertility raises US$4m seed round
Lab-grown human eggs and sperm 'about seven years away'